A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma

Archives of Ophthalmology

Volumn 118, Issue 6, 2000, Pages 773-778

  Gragoudas, Evangelos S ^a   Lane, Anne Marie ^a   Regan, Susan ^a   Li, Wenjun ^a   Judge, Heidi E ^a   Munzenrider, John E ^b   Seddon, Johanna M ^a   Egan, Kathleen M ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHOROID MELANOMA; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 0034040807     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.6.773     Document Type: Article

References (23)

1. Lommatzsch P. Beta-irradiation of choroidal melanoma with 106Ru/106Rh applicators: 16 years' experience. Arch Ophthalmol. 1983;101:713-717.
2. Shields JA, Augsburger JJ, Brady LW, Day JL. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology. 1982;89:1201-1207.
3. Stallard H. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol. 1966;50:147-155.
4. Packer S. Iodine-125 radiation of posterior uveal melanoma. Ophthalmology. 1987; 94:1621-1626.
5. Gragoudas ES, Goitein M, Koehler AM, et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol. 1977;83:665-673.
6. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation of uveal melanomas: results of 51/2-year study. Arch Ophthalmol. 1982;100:928-934.
7. Brovkina A, Zarubei G. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol. 1986;104:402-404.
8. Zografos L, Gailloud C, Perret C, et al. Rapport sur le traitement conservateur des melanomes de l'uvee a la clinique ophtalmologique universitaire de Lausanne. Klin Monatsbl Augenheilkd. 1988;192:572-578.
9. Char DH, Castro JR, Quivey JM, et al. Helium ion charged particle therapy for choroidal melanoma. Ophthalmology. 1980;87:565-570.
10. Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea. Ophthalmology. 1987;94:354-361.
11. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999;106:1571-1578.
12. Seddon JM, Gragoudas ES, Polivogianis L, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 1986;93:666-674.
13. Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992;110:475-479.
14. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995;119:157-164.
15. Egan K, Gragoudas ES, Seddon J, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989;96:1377-1383.
16. Pocock S. Clinical Trials: A Practical Approach. Chichester, England: John Wiley & Sons; 1983:80-87.
17. Seddon J, Gragoudas ES, Egan K, Polivogianis L, Finn S, Albert D. Standardized data collection and coding in eye disease epidemiology: the uveal melanoma data system. Ophthalmic Surg. 1991;22:127-136.
18. Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Suit H, Koehler A. Proton beam irradiation. Ophthalmology. 1980;87:571-581.
19. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs. Ophthalmology. 1991; 98:786-806.
20. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
21. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc. 1972;135:185-206.
22. Bentzen S, Overgaard J, Thames H, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol. 1989;16:169-182.
23. Egan K, Ryan L, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma. Arch Ophthalmol. 1998;116:366-370.